Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26830442)
Watch
English
Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
meta-analysis
1 reference
based on heuristic
inferred from title
title
Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?
(English)
1 reference
stated in
PubMed
main subject
meta-analysis
0 references
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
Ivan R. Vogelius
series ordinal
1
1 reference
stated in
Crossref
Søren M. Bentzen
series ordinal
2
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
1 January 2013
1 reference
stated in
PubMed
published in
International Journal of Radiation Oncology Biology Physics
1 reference
stated in
PubMed
volume
85
1 reference
stated in
PubMed
issue
1
1 reference
stated in
PubMed
page(s)
89-94
1 reference
stated in
PubMed
cites work
Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 September 2017
A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 September 2017
Does treatment duration affect outcome after radiotherapy for prostate cancer?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 September 2017
Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 September 2017
Weighting bias in meta-analysis of binary outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 September 2017
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
31 May 2018
Quantifying the position and steepness of radiation dose-response curves
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
31 May 2018
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 November 2018
Fractionation in prostate cancer--is it time after all?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 November 2018
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556929
retrieved
28 November 2018
Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer--the CHHiP trial
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Fractionation and protraction for radiotherapy of prostate carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
How low is the alpha/beta ratio for prostate cancer?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22652106
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
In Response to Dr. Williams
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.IJROBP.2012.03.004
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/J.IJROBP.2012.03.004
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
280350
Fatcat ID
release_4pjjigxlifahjapbkn6lgklc3m
0 references
OpenCitations bibliographic resource ID
280350
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
280350
PMCID
3556929
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
280350
PubMed ID
22652106
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
280350
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
